Race against time: High-Dose drug trial aims to keep boys walking longer
NCT ID NCT03992430
Summary
This study is testing whether higher doses of the drug eteplirsen are safe and more effective at slowing muscle decline in boys with Duchenne muscular dystrophy (DMD). It involves about 160 boys aged 4 and older who can still walk and have a specific genetic mutation. The main goal is to see if higher doses help maintain muscle function and delay the loss of walking ability over several years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCULAR DYSTROPHY, DUCHENNE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akdeniz Universitesi Tip Fakultesi
Antalya, 07059, Turkey (Türkiye)
-
All India Institute of Medical Sciences
New Delhi, 110029, India
-
Aster RV Hospital
Bengaluru, 560078, India
-
Birmingham Heartlands Hospital
Birmingham, B9 5SS, United Kingdom
-
Brno Klinika detske neurologie
Brno, 613 00, Czechia
-
CHRU de Strasbourg
Strasbourg, 67098, France
-
Charité Universitätsmedizin Berlin CVK
Berlin, 13353, Germany
-
Children's Department and Department for Children's Habilitation at Stavanger University Hospital
Stavanger, 4011, Norway
-
Children's Health Ireland (CHI) at Temple Street
Dublin, D01 XD99, Ireland
-
Christian Medical College
Vellore, 632004, India
-
Clinic for Neurology and Psychiatry for Children and Youth
Belgrade, 11000, Serbia
-
Deenanath Mangeshkar Hospital & Research Centre
Pune, 411004, India
-
Fakultni nemocnice v Motole
Prague, 150 06, Czechia
-
Fondazione Policlinico Universitario A. Gemelli- IRCCS
Rome, 00168, Italy
-
Hopital Armand Trousseau
Paris, 75571, France
-
Hopital Femme Mere Enfant
Bron, 69677, France
-
Hospital Pablo Tobón Uribe
Medellín, 50034, Colombia
-
Hospital Sant Joan de Deu
Barcelona, 8950, Spain
-
Hospital Universitari i Politecnic La Fe de Valencia
Valencia, 46026, Spain
-
Hospital Universitario San Ignacio
Bogotá, 110231, Colombia
-
IASO Children's Hospital
Marousi, Attica, 151 23, Greece
-
IRCCS Instituto Gianna Gaslini
Genova, 16147, Italy
-
Instituto Neurologico de Colombia (INDEC)
Medellín, 50012, Colombia
-
Instituto de Investigaciones Clinicas para la Salud A.C
Durango, 34000, Mexico
-
Irbid Specialty Hospital
Irbid, 22110, Jordan
-
Istiklal Hosptial (IST)
Amman, 11196, Jordan
-
Jaicare Hospital (A Unit of Sarvee Integra Pvt Ltd.)
Madurai, 626022, India
-
Kaohsiung Medical University
Kaohsiung City, 80756, Taiwan
-
Klinika Neurologii Rozwojowej
Gdansk, Pomeranian Voivodeship, 80-211, Poland
-
Kyungpook National University Chilgok Hospital
Daegu, 41404, South Korea
-
Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, LS1 3EX, United Kingdom
-
Leids Universitair Medisch Centrum
Leiden, 2333 ZC, Netherlands
-
Mersin University Medical Faculty
Mersin, 33110, Turkey (Türkiye)
-
Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"
Belgrade, 190133, Serbia
-
National Clinical Hospital for Children Neurorehabilitation "Dr. Nicolae Robănescu"
Bucharest, 41408, Romania
-
National Taiwan University Hospital
Taipei, 10071, Taiwan
-
Neurociencias Estudios Clínicos S.C.
Culiacán, Sinaloa, 80020, Mexico
-
New Zealand Clinical Research - Auckland
Auckland, 1010, New Zealand
-
Nizam's Institute of Medical Sciences
Hyderabad, 500082, India
-
Oslo Universitetssykehus HF Rikshospitalet
Oslo, 0450, Norway
-
Pharmaceutical Research Center/Jordan University of Science and Technology
Irbid, 22110, Jordan
-
Pusan National University Yangsan Hospital
Yangsan, 50612, South Korea
-
Radboud University Nijmegen Medical Centre
Nijmegen, 6525GA, Netherlands
-
Rare Disease Research, LLC
Atlanta, Georgia, 30318, United States
-
Rigshospitalet Copenhagen University Hospital
Copenhagen, 2100, Denmark
-
Royal Institute of Child Neurosciences
Ahmedabad, 380054, India
-
Samsung Medical Center
Seoul, 6351, South Korea
-
Semmelweis Egyetem Genomikai Medicina és Ritka Betegsegek Intezete
Budapest, 1082, Hungary
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Sir Ganga Ram Hospital
New Delhi, 110060, India
-
The Specialty Hospital (TSH)/Advanced Clinical Center
Amman, 11194, Jordan
-
UCL Institute of Child Health Great Ormond Street
London, WC1N 1EH, United Kingdom
-
University Children's Hospital
Belgrade, 11000, Serbia
-
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of Florida
Gainesville, Florida, 32610-3010, United States
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
-
Universitätsspital Basel
Basel, 4031, Switzerland
Conditions
Explore the condition pages connected to this study.